AMN Healthcare Services (AMN) Financials

$21.45 +0.68 (+3.29%)

Closing price 03:59 PM Eastern

Extended Trading

$21.48 +0.03 (+0.13%)

As of 06:15 PM Eastern

Annual Income Statements for AMN Healthcare Services

This table shows AMN Healthcare Services' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Income / (Loss) Attributable to Common Shareholders	-147	211	443	327	71	114	142	132	106	82	33
Consolidated Net Income / (Loss)	-147	211	444	327	71	114	142	133	106	82	33
Net Income / (Loss) Continuing Operations	-147	211	444	327	71	114	142	133	106	82	33
Total Pre-Tax Income	-173	284	607	444	92	148	187	193	176	121	59
Total Operating Income	-103	338	647	478	149	177	203	212	192	129	68
Total Gross Profit	919	1,250	1,717	1,310	792	743	696	644	620	469	316
Total Revenue	2,984	3,789	5,243	3,984	2,394	2,222	2,136	1,988	1,902	1,463	1,036
Operating Revenue	2,984	3,789	5,243	3,984	2,394	2,222	2,136	1,988	1,902	1,463	1,036
Total Cost of Revenue	2,064	2,540	3,527	2,675	1,602	1,479	1,440	1,344	1,283	994	720
Operating Cost of Revenue	2,064	2,540	3,527	2,675	1,602	1,479	1,440	1,344	1,283	994	720
Total Operating Expenses	1,022	911	1,070	832	643	567	494	432	428	340	248
Selling, General & Admin Expense	632	756	937	730	550	508	452	400	398	320	232
Depreciation Expense	167	155	133	101	93	59	41	32	30	21	16
Impairment Charge	222	0.00	0.00	-	-	-	-	-	-	-	-
Total Other Income / (Expense), net	-70	-54	-40	-34	-58	-28	-16	-20	-15	-7.79	-9.24
Interest Expense	70	54	40	34	58	28	16	20	15	7.79	9.24
Income Tax Expense	-26	74	163	117	21	35	45	60	70	39	25
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-0.41	-0.52	0.64	0.34	0.11	-0.00	-0.26	0.11	-0.10	-0.17	-0.14
Basic Earnings per Share	($3.85)	$5.38	$9.96	$6.87	$1.49	$2.44	$2.99	$2.77	$2.21	$1.72	$0.71
Weighted Average Basic Shares Outstanding	38.19M	39.17M	44.59M	47.69M	47.42M	46.70M	47.37M	47.81M	47.95M	47.53M	46.50M
Diluted Earnings per Share	($3.85)	$5.36	$9.90	$6.81	$1.48	$2.40	$2.91	$2.68	$2.15	$1.68	$0.69
Weighted Average Diluted Shares Outstanding	38.19M	39.34M	44.87M	48.05M	47.69M	47.59M	48.67M	49.43M	49.27M	48.84M	48.09M
Weighted Average Basic & Diluted Shares Outstanding	38.19M	37.89M	44.59M	47.69M	47.42M	46.85M	47.40M	47.81M	47.95M	47.53M	46.50M

This table shows AMN Healthcare Services' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-1.03	-187	7.09	16	17	13	53	61	84	82	92
Consolidated Net Income / (Loss)	-1.09	-188	6.99	16	17	12	53	61	84	82	92
Net Income / (Loss) Continuing Operations	-1.09	-188	6.99	16	17	12	53	61	84	82	92
Total Pre-Tax Income	0.18	-226	7.81	22	23	14	75	79	115	107	127
Total Operating Income	13	-203	22	38	40	34	87	92	126	119	136
Total Gross Profit	198	219	213	230	258	261	290	330	369	375	385
Total Revenue	690	735	688	741	821	818	853	991	1,126	1,126	1,139
Operating Revenue	690	735	688	741	821	818	853	991	1,126	1,126	1,139
Total Cost of Revenue	491	516	474	511	563	557	564	661	757	750	754
Operating Cost of Revenue	491	516	474	511	563	557	564	661	757	750	754
Total Operating Expenses	186	422	191	192	218	227	203	239	243	256	249
Selling, General & Admin Expense	148	159	150	149	175	185	163	202	206	219	215
Depreciation Expense	38	40	41	43	43	41	39	37	38	37	33
Total Other Income / (Expense), net	-12	-23	-14	-16	-17	-20	-12	-12	-10	-12	-8.96
Interest Expense	12	23	14	16	17	20	12	12	10	12	8.96
Income Tax Expense	1.28	-38	0.82	5.73	5.99	1.52	22	19	31	26	35
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-0.06	-0.05	-0.10	-0.18	-0.08	-0.19	-0.13	-0.05	-0.15	-0.15	0.22
Basic Earnings per Share	($0.03)	($4.91)	$0.18	$0.43	$0.45	$0.40	$1.39	$1.56	$2.03	$1.96	$2.11
Weighted Average Basic Shares Outstanding	38.31M	38.19M	38.20M	38.17M	38.11M	39.17M	38.15M	39.15M	41.38M	44.59M	43.79M
Diluted Earnings per Share	($0.03)	($4.90)	$0.18	$0.42	$0.45	$0.40	$1.39	$1.55	$2.02	$1.94	$2.10
Weighted Average Diluted Shares Outstanding	38.31M	38.19M	38.29M	38.23M	38.20M	39.34M	38.33M	39.34M	41.57M	44.87M	44.04M
Weighted Average Basic & Diluted Shares Outstanding	38.28M	38.19M	38.07M	38.00M	38.00M	37.89M	37.79M	37.99M	39.65M	44.59M	43.34M

This table details how cash moves in and out of AMN Healthcare Services' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Change in Cash & Equivalents	-19	-30	-109	163	-70	70	-15	48	2.11	-3.50	-2.51
Net Cash From Operating Activities	320	372	654	305	257	225	227	161	134	56	28
Net Cash From Continuing Operating Activities	320	372	654	305	257	225	227	161	134	56	28
Net Income / (Loss) Continuing Operations	-147	211	444	327	71	114	142	133	106	82	33
Consolidated Net Income / (Loss)	-147	211	444	327	71	114	142	133	106	82	33
Depreciation Expense	174	161	137	104	94	59	41	32	30	21	16
Non-Cash Adjustments To Reconcile Net Income	306	212	72	-131	40	3.09	6.54	31	24	-11	4.12
Changes in Operating Assets and Liabilities, net	-12	-212	0.90	5.60	52	50	38	-35	-26	-36	-26
Net Cash From Investing Activities	-80	-412	-171	-107	-538	-292	-279	-35	-258	-116	-28
Net Cash From Continuing Investing Activities	-80	-412	-171	-107	-538	-292	-279	-35	-258	-116	-28
Purchase of Property, Plant & Equipment	-81	-104	-76	-54	-38	-35	-35	-27	-22	-27	-19
Acquisitions	0.00	-294	-75	-41	-478	-249	-225	-3.50	-218	-86	-19
Purchase of Investments	-1.38	0.00	-13	-61	-48	-26	-34	-15	-13	0.00	0.00
Divestitures	1.65	0.00	0.00	-	0.07	0.00	0.00	-	-	-	-
Sale and/or Maturity of Investments	9.10	9.97	14	58	33	32	25	20	2.00	0.00	0.00
Other Investing Activities, net	-8.41	-25	-22	-8.99	-7.66	-13	-11	-11	-6.91	-3.00	10
Net Cash From Financing Activities	-259	11	-592	-35	211	137	38	-77	126	56	-2.10
Net Cash From Continuing Financing Activities	-259	11	-592	-35	211	137	38	-77	126	56	-2.10
Repayment of Debt	-376	-359	0.00	-92	-818	-376	-77	-44	-381	-33	-199
Repurchase of Common Equity	0.00	-425	-577	-2.69	0.00	-19	-67	-20	-13	0.00	0.00
Issuance of Debt	125	815	0.00	70	1,047	551	195	0.00	524	90	198
Other Financing Activities, net	-8.48	-21	-15	-10	-18	-19	-13	-13	-3.57	-4.46	-2.63
Cash Interest Paid	61	48	38	38	23	24	21	18	8.06	5.81	4.60
Cash Income Taxes Paid	28	78	214	106	46	38	31	74	73	33	18

This table details how cash moves in and out of AMN Healthcare Services' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	5.41	-21	-16	-2.93	21	-1.37	33	-28	-33	-84	78
Net Cash From Operating Activities	93	73	67	100	81	-41	172	198	43	115	114
Net Cash From Continuing Operating Activities	93	73	67	100	81	-41	172	198	43	115	114
Net Income / (Loss) Continuing Operations	-1.09	-188	6.99	16	17	12	53	61	84	82	92
Consolidated Net Income / (Loss)	-1.09	-188	6.99	16	17	12	53	61	84	82	92
Depreciation Expense	40	41	43	45	45	43	41	38	39	38	34
Non-Cash Adjustments To Reconcile Net Income	18	232	16	30	28	68	-2.76	117	30	33	7.72
Changes in Operating Assets and Liabilities, net	36	-13	0.26	8.59	-8.20	-164	81	-19	-110	-37	-21
Net Cash From Investing Activities	-26	-14	-22	-22	-21	-324	-34	-22	-32	-23	-32
Net Cash From Continuing Investing Activities	-26	-14	-22	-22	-21	-324	-34	-22	-32	-23	-32
Purchase of Property, Plant & Equipment	-9.98	-16	-19	-27	-18	-30	-30	-26	-17	-25	-20
Purchase of Investments	-22	-	-	-	-	-	-	-	-	-	-2.49
Sale and/or Maturity of Investments	7.24	3.40	1.21	3.29	1.21	-	2.98	4.98	2.01	1.84	3.46
Other Investing Activities, net	-1.59	-	-3.95	-	-4.46	-	-6.99	-0.96	-17	-0.11	-8.83
Net Cash From Financing Activities	-61	-80	-60	-80	-39	363	-105	-203	-44	-176	-3.84
Net Cash From Continuing Financing Activities	-61	-80	-60	-80	-39	363	-105	-203	-44	-176	-3.84
Repayment of Debt	-95	-116	-120	-90	-50	-25	-110	-150	-74	-	-
Issuance of Debt	35	40	60	10	15	390	15	200	210	-	-
Other Financing Activities, net	-1.21	-3.93	-0.47	-0.11	-3.97	-1.21	-10	-3.29	-6.13	-1.47	-3.84
Cash Interest Paid	2.94	23	5.40	25	7.54	23	2.44	22	1.05	19	0.06
Cash Income Taxes Paid	2.14	6.48	4.10	13	4.31	67	1.10	4.33	5.40	49	44

This table presents AMN Healthcare Services' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Total Assets	2,416	2,924	2,888	3,132	2,354	1,932	1,493	1,254	1,187	880	681
Total Current Assets	595	842	1,094	1,349	534	560	482	474	451	376	283
Cash & Equivalents	11	33	65	181	29	83	14	15	11	9.58	13
Accounts Receivable	508	741	944	1,029	450	425	416	392	391	329	215
Prepaid Expenses	23	22	19	72	14	12	12	17	14	14	10
Other Current Assets	53	46	66	67	41	40	40	51	35	24	17
Plant, Property, & Equipment, net	186	191	149	127	116	105	90	73	60	50	33
Total Noncurrent Assets	1,635	1,891	1,645	1,656	1,704	1,266	920	706	676	455	365
Long-Term Investments	72	69	61	64	61	62	59	-	-	-	-
Goodwill	897	1,112	935	892	864	596	439	341	342	205	154
Intangible Assets	381	474	477	514	565	398	326	227	246	175	153
Noncurrent Deferred & Refundable Income Taxes	26	0.00	-	-	-	-	-	-	-	-	-
Other Noncurrent Operating Assets	258	237	172	184	213	210	96	74	58	48	39
Total Liabilities & Shareholders' Equity	2,416	2,924	2,888	3,132	2,354	1,932	1,493	1,254	1,187	880	681
Total Liabilities	1,709	2,093	1,845	1,970	1,534	1,195	854	691	737	533	424
Total Current Liabilities	546	656	858	969	423	378	307	265	275	251	178
Accounts Payable	184	344	476	425	168	156	150	130	138	119	79
Current Employee Benefit Liabilities	288	279	333	354	213	171	135	121	108	84	68
Other Current Liabilities	74	34	48	174	26	39	10	5.15	17	5.37	2.63
Total Noncurrent Liabilities	1,163	1,437	987	1,000	1,111	817	546	426	463	282	246
Long-Term Debt	1,056	1,305	844	842	858	617	441	320	359	181	136
Noncurrent Deferred & Payable Income Tax Liabilities	0.00	23	23	48	67	47	27	27	21	22	32
Other Noncurrent Operating Liabilities	107	109	121	110	186	153	79	79	82	78	78
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	707	831	1,044	1,162	820	737	639	563	449	348	257
Total Preferred & Common Equity	707	831	1,044	1,162	820	737	639	563	449	348	257
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	707	831	1,044	1,162	820	737	639	563	449	348	257
Common Stock	529	507	502	487	469	456	453	454	453	444	435
Retained Earnings	1,305	1,452	1,241	797	470	400	286	142	9.67	-96	-178
Treasury Stock	-1,127	-1,127	-699	-122	-119	-119	-100	-33	-13	0.00	-
Accumulated Other Comprehensive Income / (Loss)	-0.01	-0.42	-0.94	-0.30	0.04	0.15	0.15	-0.11	0.00	-0.18	-0.36

This table presents AMN Healthcare Services' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	2,395	2,668	2,771	2,874	2,655	2,644	2,881	3,018
Total Current Assets	627	612	705	791	831	807	1,071	1,206
Cash & Equivalents	56	31	48	51	29	7.01	29	156
Accounts Receivable	487	520	590	676	742	748	964	979
Prepaid Expenses	25	17	20	25	18	18	27	17
Other Current Assets	60	45	47	39	42	34	52	55
Plant, Property, & Equipment, net	178	197	197	195	188	177	155	141
Total Noncurrent Assets	1,590	1,859	1,870	1,888	1,636	1,659	1,655	1,671
Long-Term Investments	45	72	72	72	70	72	68	65
Goodwill	897	1,117	1,116	1,115	936	936	935	936
Intangible Assets	362	402	425	449	410	432	454	499
Noncurrent Deferred & Refundable Income Taxes	32	-	-	-	-	-	-	-
Other Noncurrent Operating Assets	254	267	257	252	221	220	197	171
Total Liabilities & Shareholders' Equity	2,395	2,668	2,771	2,874	2,655	2,644	2,881	3,018
Total Liabilities	1,680	1,777	1,894	2,019	1,838	1,878	1,925	1,886
Total Current Liabilities	582	519	574	624	707	674	804	891
Accounts Payable	196	213	283	316	363	328	474	459
Current Employee Benefit Liabilities	269	282	268	281	264	262	269	339
Other Current Liabilities	117	24	22	27	81	85	61	78
Total Noncurrent Liabilities	1,098	1,259	1,321	1,396	1,130	1,204	1,122	994
Long-Term Debt	996	1,131	1,190	1,270	939	1,034	984	843
Other Noncurrent Operating Liabilities	102	111	110	110	160	163	122	109
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	715	891	877	854	817	766	956	1,133
Total Preferred & Common Equity	715	891	877	854	817	766	956	1,133
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	715	891	877	854	817	766	956	1,133
Common Stock	538	526	519	513	506	468	506	498
Retained Earnings	1,304	1,492	1,485	1,469	1,439	1,386	1,325	1,159
Treasury Stock	-1,127	-1,127	-1,127	-1,127	-1,127	-1,087	-875	-524
Accumulated Other Comprehensive Income / (Loss)	0.05	-0.06	-0.16	-0.34	-0.61	-0.74	-0.79	-1.09

This table displays calculated financial ratios and metrics derived from AMN Healthcare Services' official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-21.26%	-27.73%	31.60%	66.45%	7.72%	4.03%	7.42%	4.53%	30.02%	41.22%	2.39%
EBITDA Growth	-85.76%	-36.32%	34.82%	138.94%	3.54%	-3.58%	-0.30%	10.55%	47.67%	78.59%	6.13%
EBIT Growth	-130.34%	-47.70%	35.38%	220.23%	-15.63%	-12.78%	-4.52%	10.86%	48.69%	89.80%	3.67%
NOPAT Growth	-128.66%	-47.05%	34.35%	205.88%	-15.14%	-11.81%	5.41%	26.89%	32.09%	126.70%	-0.48%
Net Income Growth	-169.76%	-52.56%	35.63%	363.30%	-38.01%	-19.58%	6.93%	25.25%	29.24%	146.53%	0.86%
EPS Growth	-171.83%	-45.86%	45.37%	360.14%	-38.33%	-17.53%	8.58%	24.65%	27.98%	143.48%	0.00%
Operating Cash Flow Growth	-13.90%	-43.07%	114.09%	18.90%	14.21%	-0.94%	41.41%	19.87%	137.79%	103.46%	-54.00%
Free Cash Flow Firm Growth	1,385.11%	-104.66%	154.20%	169.22%	-302.51%	-34.38%	-143.58%	190.25%	-120.31%	-537.28%	-153.81%
Invested Capital Growth	-17.41%	15.49%	0.14%	10.50%	31.69%	20.10%	25.35%	4.22%	45.52%	37.47%	14.04%
Revenue Q/Q Growth	-2.72%	-7.50%	-4.33%	22.50%	1.89%	2.69%	0.92%	1.08%	4.70%	9.17%	3.08%
EBITDA Q/Q Growth	-77.02%	-13.81%	-4.75%	32.79%	-4.36%	1.05%	-0.08%	1.75%	7.71%	14.19%	4.10%
EBIT Q/Q Growth	-176.59%	-20.09%	-7.08%	41.39%	-10.93%	-1.78%	-1.47%	1.64%	7.54%	15.58%	4.50%
NOPAT Q/Q Growth	-167.82%	-20.10%	-6.48%	37.68%	-4.27%	-0.74%	-6.19%	11.43%	8.36%	13.92%	3.17%
Net Income Q/Q Growth	-377.09%	-24.75%	-7.19%	48.49%	-20.46%	-6.66%	-3.77%	12.58%	6.21%	14.34%	4.86%
EPS Q/Q Growth	-365.52%	-22.32%	-4.53%	48.37%	-21.28%	-5.51%	-3.32%	12.13%	5.91%	15.07%	4.55%
Operating Cash Flow Q/Q Growth	55.19%	-29.60%	6.06%	14.27%	-13.13%	9.61%	0.23%	6.17%	56.63%	-7.41%	-27.76%
Free Cash Flow Firm Q/Q Growth	281.70%	-105.33%	8.30%	13.12%	-6.92%	13.55%	-9.84%	5.63%	25.81%	6.15%	56.33%
Invested Capital Q/Q Growth	-12.43%	22.75%	0.35%	4.46%	0.01%	-0.99%	-0.07%	0.63%	-0.50%	6.23%	6.69%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	30.81%	32.98%	32.74%	32.87%	33.08%	33.46%	32.60%	32.41%	32.58%	32.08%	30.51%
EBITDA Margin	2.38%	13.18%	14.96%	14.60%	10.17%	10.58%	11.42%	12.30%	11.63%	10.24%	8.10%
Operating Margin	-3.44%	8.93%	12.34%	12.00%	6.24%	7.96%	9.50%	10.68%	10.07%	8.81%	6.55%
EBIT Margin	-3.44%	8.93%	12.34%	12.00%	6.24%	7.96%	9.50%	10.68%	10.07%	8.81%	6.55%
Profit (Net Income) Margin	-4.93%	5.56%	8.47%	8.22%	2.95%	5.13%	6.64%	6.67%	5.56%	5.60%	3.21%
Tax Burden Percent	85.17%	74.11%	73.19%	73.75%	77.21%	76.77%	75.93%	68.77%	60.08%	67.63%	56.62%
Interest Burden Percent	168.08%	84.00%	93.76%	92.87%	61.32%	83.93%	92.04%	90.74%	91.93%	93.96%	86.40%
Effective Tax Rate	0.00%	25.89%	26.81%	26.25%	22.79%	23.23%	24.07%	31.23%	39.92%	32.37%	43.38%
Return on Invested Capital (ROIC)	-3.87%	13.22%	26.91%	21.04%	8.23%	12.26%	17.02%	18.57%	17.71%	19.06%	10.64%
ROIC Less NNEP Spread (ROIC-NNEP)	-10.77%	9.04%	22.41%	17.37%	1.06%	7.06%	12.99%	13.75%	14.02%	15.66%	6.43%
Return on Net Nonoperating Assets (RNNOA)	-15.24%	9.26%	13.36%	12.00%	0.85%	4.31%	6.57%	7.63%	8.84%	8.04%	3.37%
Return on Equity (ROE)	-19.11%	22.47%	40.26%	33.04%	9.08%	16.57%	23.59%	26.20%	26.55%	27.10%	14.01%
Cash Return on Invested Capital (CROIC)	15.20%	-1.16%	26.77%	11.06%	-19.12%	-6.01%	-5.47%	14.44%	-19.37%	-12.49%	-2.48%
Operating Return on Assets (OROA)	-3.85%	11.64%	21.50%	17.43%	6.97%	10.33%	14.77%	17.41%	18.54%	16.51%	10.57%
Return on Assets (ROA)	-5.50%	7.25%	14.75%	11.94%	3.30%	6.66%	10.32%	10.86%	10.24%	10.49%	5.17%
Return on Common Equity (ROCE)	-19.11%	22.47%	40.26%	33.04%	9.08%	16.57%	23.59%	26.20%	26.55%	27.10%	14.01%
Return on Equity Simple (ROE_SIMPLE)	-20.80%	25.34%	42.55%	28.17%	8.62%	15.47%	22.18%	23.56%	23.55%	23.54%	12.95%
Net Operating Profit after Tax (NOPAT)	-72	251	474	353	115	136	154	146	115	87	38
NOPAT Margin	-2.41%	6.62%	9.03%	8.85%	4.81%	6.11%	7.21%	7.35%	6.05%	5.96%	3.71%
Net Nonoperating Expense Percent (NNEP)	6.90%	4.18%	4.50%	3.67%	7.17%	5.20%	4.03%	4.82%	3.70%	3.40%	4.21%
Return On Investment Capital (ROIC_SIMPLE)	-4.08%	11.74%	25.10%	-	-	-	-	-	-	-	-
Cost of Revenue to Revenue	69.19%	67.02%	67.26%	67.13%	66.92%	66.54%	67.40%	67.59%	67.42%	67.92%	69.49%
SG&A Expenses to Revenue	21.20%	19.96%	17.86%	18.33%	22.97%	22.86%	21.18%	20.10%	20.95%	21.84%	22.41%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	34.25%	24.05%	20.40%	20.87%	26.84%	25.50%	23.11%	21.72%	22.50%	23.27%	23.96%
Earnings before Interest and Taxes (EBIT)	-103	338	647	478	149	177	203	212	192	129	68
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	71	499	784	582	243	235	244	245	221	150	84
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.29	3.40	4.27	4.98	3.92	3.95	4.16	4.18	4.11	4.26	3.56
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.31	0.75	0.85	1.45	1.34	1.31	1.24	1.18	0.97	1.01	0.88
Price to Earnings (P/E)	0.00	13.40	10.05	17.68	45.50	25.53	18.70	17.76	17.43	18.05	27.40
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	7.46%	9.95%	5.66%	2.20%	3.92%	5.35%	5.63%	5.74%	5.54%	3.65%
Enterprise Value to Invested Capital (EV/IC)	1.12	1.98	2.94	3.63	2.50	2.80	3.00	3.31	2.86	3.19	2.76
Enterprise Value to Revenue (EV/Rev)	0.63	1.06	0.99	1.60	1.66	1.52	1.42	1.34	1.16	1.16	1.03
Enterprise Value to EBITDA (EV/EBITDA)	26.50	8.08	6.60	10.97	16.36	14.39	12.40	10.87	9.94	11.28	12.66
Enterprise Value to EBIT (EV/EBIT)	0.00	11.92	8.00	13.35	26.68	19.12	14.90	12.51	11.48	13.11	15.64
Enterprise Value to NOPAT (EV/NOPAT)	0.00	16.08	10.92	18.10	34.55	24.91	19.63	18.19	19.11	19.39	27.63
Enterprise Value to Operating Cash Flow (EV/OCF)	5.88	10.84	7.91	20.89	15.50	15.04	13.32	16.56	16.43	30.01	38.37
Enterprise Value to Free Cash Flow (EV/FCFF)	6.67	0.00	10.98	34.42	0.00	0.00	0.00	23.39	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.49	1.57	0.81	0.72	1.05	0.84	0.69	0.57	0.81	0.63	0.63
Long-Term Debt to Equity	1.49	1.57	0.81	0.72	1.05	0.84	0.69	0.57	0.80	0.52	0.53
Financial Leverage	1.42	1.02	0.60	0.69	0.80	0.61	0.51	0.55	0.63	0.51	0.52
Leverage Ratio	3.47	3.10	2.73	2.77	2.75	2.49	2.29	2.41	2.59	2.58	2.71
Compound Leverage Factor	5.84	2.60	2.56	2.57	1.69	2.09	2.10	2.19	2.38	2.43	2.34
Debt to Total Capital	59.91%	61.08%	44.70%	42.02%	51.28%	45.58%	40.81%	36.25%	44.68%	38.58%	38.58%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.28%	0.00%	0.00%	0.00%	0.46%	6.62%	6.10%
Long-Term Debt to Total Capital	59.91%	61.08%	44.70%	42.02%	51.00%	45.58%	40.81%	36.25%	44.22%	31.96%	32.48%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	40.09%	38.92%	55.30%	57.98%	48.72%	54.42%	59.19%	63.75%	55.32%	61.42%	61.42%
Debt to EBITDA	14.85	2.61	1.08	1.45	3.54	2.62	1.81	1.31	1.64	1.46	1.92
Net Debt to EBITDA	13.69	2.41	0.92	1.03	3.17	2.01	1.51	1.25	1.59	1.39	1.77
Long-Term Debt to EBITDA	14.85	2.61	1.08	1.45	3.52	2.62	1.81	1.31	1.62	1.21	1.62
Debt to NOPAT	-14.69	5.20	1.78	2.39	7.49	4.54	2.86	2.19	3.15	2.51	4.19
Net Debt to NOPAT	-13.54	4.80	1.52	1.69	6.70	3.48	2.39	2.09	3.06	2.40	3.85
Long-Term Debt to NOPAT	-14.69	5.20	1.78	2.39	7.44	4.54	2.86	2.19	3.12	2.08	3.53
Altman Z-Score	2.20	3.26	4.70	4.04	2.82	3.32	4.15	4.55	3.83	3.83	2.96
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.09	1.28	1.27	1.39	1.26	1.48	1.57	1.79	1.64	1.50	1.59
Quick Ratio	0.95	1.18	1.18	1.25	1.13	1.34	1.40	1.53	1.46	1.35	1.28
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	282	-22	471	185	-268	-67	-50	114	-126	-57	-8.96
Operating Cash Flow to CapEx	396.11%	358.93%	862.09%	569.98%	681.20%	638.49%	644.76%	605.07%	609.90%	208.49%	144.65%
Free Cash Flow to Firm to Interest Expense	4.04	-0.41	11.66	5.44	-4.64	-2.34	-3.07	5.77	-8.14	-7.33	-0.97
Operating Cash Flow to Interest Expense	4.58	6.87	16.18	8.96	4.45	7.91	14.06	8.16	8.66	7.23	3.00
Operating Cash Flow Less CapEx to Interest Expense	3.43	4.96	14.31	7.39	3.79	6.67	11.88	6.81	7.24	3.76	0.93
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.12	1.30	1.74	1.45	1.12	1.30	1.56	1.63	1.84	1.87	1.61
Accounts Receivable Turnover	4.78	4.50	5.31	5.39	5.47	5.28	5.29	5.08	5.28	5.38	5.45
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	15.80	22.25	37.94	32.75	21.66	22.76	26.07	29.82	34.56	35.25	38.34
Accounts Payable Turnover	7.82	6.19	7.82	9.02	9.89	9.67	10.29	10.04	10.01	10.05	9.58
Days Sales Outstanding (DSO)	76.42	81.18	68.68	67.74	66.75	69.10	68.99	71.84	69.08	67.80	67.02
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	46.69	58.95	46.66	40.47	36.91	37.74	35.48	36.37	36.48	36.33	38.10
Cash Conversion Cycle (CCC)	29.73	22.23	22.02	27.27	29.83	31.37	33.51	35.47	32.60	31.47	28.92
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,680	2,034	1,761	1,759	1,592	1,209	1,006	803	770	529	385
Invested Capital Turnover	1.61	2.00	2.98	2.38	1.71	2.01	2.36	2.53	2.93	3.20	2.87
Increase / (Decrease) in Invested Capital	-354	273	2.46	167	383	202	204	32	241	144	47
Enterprise Value (EV)	1,884	4,033	5,174	6,380	3,982	3,383	3,023	2,657	2,200	1,690	1,062
Market Capitalization	911	2,830	4,456	5,783	3,210	2,911	2,656	2,353	1,848	1,481	914
Book Value per Share	$18.56	$22.00	$24.08	$24.58	$17.43	$15.77	$13.63	$11.78	$9.35	$7.29	$5.50
Tangible Book Value per Share	($15.03)	($19.96)	($8.50)	($5.18)	($12.96)	($5.51)	($2.68)	($0.11)	($2.87)	($0.67)	($1.08)
Total Capital	1,762	2,136	1,887	2,004	1,682	1,354	1,080	882	812	566	418
Total Debt	1,056	1,305	844	842	863	617	441	320	363	218	161
Total Long-Term Debt	1,056	1,305	844	842	858	617	441	320	359	181	136
Net Debt	973	1,203	718	597	772	472	367	305	352	209	148
Capital Expenditures (CapEx)	81	104	76	54	38	35	35	27	22	27	19
Debt-free, Cash-free Net Working Capital (DFCFNWC)	38	153	171	199	86	99	161	194	169	153	117
Debt-free Net Working Capital (DFNWC)	49	186	236	380	115	182	175	209	180	162	130
Net Working Capital (NWC)	49	186	236	380	111	182	175	209	176	125	104
Net Nonoperating Expense (NNE)	75	40	30	25	45	22	12	14	9.29	5.27	5.23
Net Nonoperating Obligations (NNO)	973	1,203	718	597	772	472	367	240	321	182	129
Total Depreciation and Amortization (D&A)	174	161	137	104	94	58	41	32	30	21	16
Debt-free, Cash-free Net Working Capital to Revenue	1.29%	4.03%	3.26%	4.99%	3.60%	4.47%	7.54%	9.74%	8.88%	10.43%	11.27%
Debt-free Net Working Capital to Revenue	1.65%	4.90%	4.50%	9.53%	4.82%	8.21%	8.19%	10.50%	9.44%	11.08%	12.54%
Net Working Capital to Revenue	1.65%	4.90%	4.50%	9.53%	4.63%	8.21%	8.19%	10.50%	9.24%	8.52%	10.07%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($3.85)	$5.38	$9.96	$6.87	$1.49	$2.44	$2.99	$2.77	$2.21	$1.72	$0.71
Adjusted Weighted Average Basic Shares Outstanding	38.19M	39.17M	44.59M	47.69M	47.42M	46.70M	47.37M	47.81M	47.95M	47.53M	46.50M
Adjusted Diluted Earnings per Share	($3.85)	$5.36	$9.90	$6.81	$1.48	$2.40	$2.91	$2.68	$2.15	$1.68	$0.69
Adjusted Weighted Average Diluted Shares Outstanding	38.19M	39.34M	44.87M	48.05M	47.69M	47.59M	48.67M	49.43M	49.27M	48.84M	48.09M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	38.19M	37.89M	44.59M	46.64M	47.18M	46.85M	46.87M	47.66M	47.72M	47.53M	46.50M
Normalized Net Operating Profit after Tax (NOPAT)	84	251	474	353	115	136	154	146	115	87	38
Normalized NOPAT Margin	2.81%	6.62%	9.03%	8.85%	4.81%	6.11%	7.21%	7.35%	6.05%	5.96%	3.71%
Pre Tax Income Margin	-5.78%	7.50%	11.57%	11.14%	3.82%	6.68%	8.74%	9.69%	9.26%	8.28%	5.66%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-1.47	6.25	16.02	14.03	2.59	6.22	12.56	10.80	12.39	16.54	7.35
NOPAT to Interest Expense	-1.03	4.63	11.72	10.34	2.00	4.78	9.54	7.42	7.44	11.19	4.16
EBIT Less CapEx to Interest Expense	-2.63	4.34	14.14	12.45	1.93	4.98	10.38	9.45	10.97	13.08	5.28
NOPAT Less CapEx to Interest Expense	-2.19	2.72	9.85	8.77	1.34	3.54	7.36	6.08	6.02	7.72	2.09
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	201.61%	129.89%	0.82%	0.00%	16.41%	47.28%	15.21%	12.53%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from AMN Healthcare Services' official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-16.00%	-10.21%	-19.44%	-25.28%	-27.11%	-27.30%	-25.04%	-30.51%	-27.46%	-17.43%	29.71%
EBITDA Growth	-38.00%	-308.37%	-48.84%	-36.55%	-48.66%	-50.85%	-25.22%	-40.08%	-31.30%	-19.92%	28.71%
EBIT Growth	-68.69%	-692.78%	-74.40%	-58.89%	-68.21%	-71.35%	-36.26%	-50.06%	-39.56%	-29.26%	28.86%
NOPAT Growth	-351.41%	-565.31%	-67.52%	-60.34%	-67.59%	-66.42%	-38.03%	-46.38%	-40.17%	-26.45%	27.07%
Net Income Growth	-106.30%	-1,601.59%	-86.86%	-73.34%	-79.40%	-84.73%	-42.48%	-50.80%	-42.39%	-29.62%	24.89%
EPS Growth	-106.67%	-1,325.00%	-87.05%	-72.90%	-77.72%	-79.38%	-33.81%	-44.04%	-34.63%	-19.50%	36.36%
Operating Cash Flow Growth	13.87%	277.03%	-61.26%	-49.66%	87.38%	-135.66%	51.41%	-11.94%	-78.31%	47.88%	579.14%
Free Cash Flow Firm Growth	346.36%	187.65%	-251.49%	-320.69%	-1,566.41%	-374.42%	478.00%	1,897.06%	-113.13%	301.66%	292.39%
Invested Capital Growth	-19.55%	-17.41%	15.77%	13.10%	8.58%	15.49%	-5.59%	-1.11%	5.69%	0.14%	4.24%
Revenue Q/Q Growth	-6.15%	6.87%	-7.18%	-9.77%	0.32%	-4.12%	-13.90%	-11.98%	0.06%	-1.15%	-20.19%
EBITDA Q/Q Growth	132.51%	-346.67%	-20.77%	-2.42%	9.26%	-39.44%	-1.73%	-21.04%	4.59%	-7.85%	-21.26%
EBIT Q/Q Growth	106.17%	-1,010.26%	-40.95%	-5.67%	16.90%	-60.69%	-5.17%	-27.06%	5.37%	-12.54%	-25.70%
NOPAT Q/Q Growth	47.36%	-811.85%	-28.49%	-6.17%	-2.58%	-50.30%	-12.70%	-23.31%	0.92%	-8.28%	-24.46%
Net Income Q/Q Growth	99.42%	-2,783.26%	-56.96%	-6.30%	38.75%	-76.51%	-12.70%	-27.59%	2.83%	-11.52%	-25.33%
EPS Q/Q Growth	99.39%	-2,822.22%	-57.14%	-6.67%	12.50%	-71.22%	-10.32%	-23.27%	4.12%	-7.62%	-24.19%
Operating Cash Flow Q/Q Growth	27.27%	9.16%	-32.97%	22.28%	297.88%	-123.89%	-12.89%	355.10%	-62.34%	1.41%	-49.33%
Free Cash Flow Firm Q/Q Growth	49.12%	187.97%	-22.12%	-53.78%	46.94%	-252.04%	77.91%	1,261.14%	-108.74%	220.24%	653.13%
Invested Capital Q/Q Growth	-4.14%	-12.43%	-1.48%	-2.72%	-1.60%	22.75%	-3.75%	-6.60%	4.66%	0.35%	0.81%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	28.73%	29.81%	30.99%	31.03%	31.37%	31.89%	33.92%	33.32%	32.75%	33.34%	33.82%
EBITDA Margin	7.59%	-21.92%	9.50%	11.13%	10.29%	9.45%	14.96%	13.10%	14.61%	13.98%	14.99%
Operating Margin	1.81%	-27.57%	3.24%	5.09%	4.87%	4.18%	10.19%	9.25%	11.16%	10.60%	11.98%
EBIT Margin	1.81%	-27.57%	3.24%	5.09%	4.87%	4.18%	10.19%	9.25%	11.16%	10.60%	11.98%
Profit (Net Income) Margin	-0.16%	-25.52%	1.02%	2.19%	2.11%	1.53%	6.23%	6.14%	7.47%	7.27%	8.12%
Tax Burden Percent	-596.72%	83.10%	89.51%	73.92%	74.31%	89.18%	70.54%	76.62%	72.88%	76.09%	72.56%
Interest Burden Percent	1.46%	111.41%	35.09%	58.30%	58.37%	40.99%	86.72%	86.72%	91.84%	90.13%	93.43%
Effective Tax Rate	696.72%	0.00%	10.49%	26.08%	25.69%	10.82%	29.46%	23.38%	27.12%	23.91%	27.44%
Return on Invested Capital (ROIC)	-17.09%	-31.01%	4.97%	6.63%	6.55%	7.44%	17.25%	17.93%	21.84%	24.02%	27.70%
ROIC Less NNEP Spread (ROIC-NNEP)	-9.89%	-35.21%	3.59%	5.48%	5.34%	5.56%	16.14%	16.80%	20.87%	22.66%	26.67%
Return on Net Nonoperating Assets (RNNOA)	-12.88%	-49.83%	3.92%	6.76%	6.00%	5.70%	12.10%	15.42%	15.89%	13.50%	15.50%
Return on Equity (ROE)	-29.98%	-80.83%	8.89%	13.39%	12.56%	13.13%	29.35%	33.35%	37.73%	37.52%	43.20%
Cash Return on Invested Capital (CROIC)	16.63%	15.20%	-8.69%	-4.31%	1.61%	-1.16%	24.14%	21.41%	17.44%	26.77%	25.30%
Operating Return on Assets (OROA)	1.96%	-30.81%	3.73%	6.07%	5.89%	5.44%	14.71%	14.33%	17.54%	18.46%	22.92%
Return on Assets (ROA)	-0.17%	-28.52%	1.17%	2.62%	2.56%	1.99%	9.00%	9.52%	11.74%	12.66%	15.54%
Return on Common Equity (ROCE)	-29.98%	-80.83%	8.89%	13.39%	12.56%	13.13%	29.35%	33.35%	37.73%	37.52%	43.20%
Return on Equity Simple (ROE_SIMPLE)	-23.13%	0.00%	5.96%	11.32%	16.85%	0.00%	34.26%	41.66%	39.98%	0.00%	42.24%
Net Operating Profit after Tax (NOPAT)	-75	-142	20	28	30	30	61	70	92	91	99
NOPAT Margin	-10.82%	-19.30%	2.90%	3.76%	3.62%	3.72%	7.18%	7.09%	8.13%	8.06%	8.69%
Net Nonoperating Expense Percent (NNEP)	-7.20%	4.20%	1.38%	1.15%	1.21%	1.87%	1.11%	1.13%	0.96%	1.36%	1.03%
Return On Investment Capital (ROIC_SIMPLE)	-4.36%	-8.04%	-	-	-	1.43%	-	-	-	4.81%	-
Cost of Revenue to Revenue	71.27%	70.19%	69.01%	68.97%	68.63%	68.11%	66.08%	66.68%	67.25%	66.66%	66.18%
SG&A Expenses to Revenue	21.42%	21.63%	21.77%	20.12%	21.30%	22.67%	19.15%	20.35%	18.26%	19.47%	18.92%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	26.92%	57.38%	27.75%	25.94%	26.50%	27.71%	23.74%	24.07%	21.59%	22.74%	21.84%
Earnings before Interest and Taxes (EBIT)	13	-203	22	38	40	34	87	92	126	119	136
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	52	-161	65	82	84	77	128	130	165	157	171
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.31	1.29	1.81	2.22	2.77	3.40	3.96	5.65	3.56	4.27	4.05
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.33	0.31	0.53	0.60	0.68	0.75	0.79	0.99	0.71	0.85	0.84
Price to Earnings (P/E)	0.00	0.00	30.06	19.50	16.36	13.40	11.54	13.55	8.91	10.05	9.61
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	3.33%	5.13%	6.11%	7.46%	8.67%	7.38%	11.23%	9.95%	10.41%
Enterprise Value to Invested Capital (EV/IC)	1.14	1.12	1.38	1.55	1.75	1.98	2.46	3.07	2.33	2.94	2.97
Enterprise Value to Revenue (EV/Rev)	0.64	0.63	0.86	0.93	1.01	1.06	1.00	1.21	0.89	0.99	0.95
Enterprise Value to EBITDA (EV/EBITDA)	46.90	26.50	8.53	8.11	8.37	8.08	7.04	8.49	6.05	6.60	6.33
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	19.69	15.18	13.89	11.92	9.62	11.17	7.60	8.00	7.48
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	24.90	20.61	18.55	16.08	12.99	15.03	10.42	10.92	10.28
Enterprise Value to Operating Cash Flow (EV/OCF)	5.52	5.88	12.78	9.67	8.56	10.84	7.71	11.23	8.64	7.91	8.45
Enterprise Value to Free Cash Flow (EV/FCFF)	6.09	6.67	0.00	0.00	113.35	0.00	9.89	14.25	13.73	10.98	11.97
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.39	1.49	1.27	1.36	1.49	1.57	1.15	1.35	1.03	0.81	0.74
Long-Term Debt to Equity	1.39	1.49	1.27	1.36	1.49	1.57	1.15	1.35	1.03	0.81	0.74
Financial Leverage	1.30	1.42	1.09	1.23	1.12	1.02	0.75	0.92	0.76	0.60	0.58
Leverage Ratio	3.36	3.47	3.12	3.30	3.18	3.10	2.91	3.13	3.01	2.73	2.63
Compound Leverage Factor	0.05	3.87	1.09	1.92	1.86	1.27	2.52	2.71	2.76	2.46	2.46
Debt to Total Capital	58.21%	59.91%	55.93%	57.58%	59.79%	61.08%	53.48%	57.44%	50.72%	44.70%	42.68%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	58.21%	59.91%	55.93%	57.58%	59.79%	61.08%	53.48%	57.44%	50.72%	44.70%	42.68%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	41.79%	40.09%	44.07%	42.42%	40.21%	38.92%	46.52%	42.56%	49.28%	55.30%	57.32%
Debt to EBITDA	25.54	14.85	3.65	3.20	3.03	2.61	1.62	1.66	1.39	1.08	1.02
Net Debt to EBITDA	22.95	13.69	3.32	2.88	2.74	2.41	1.45	1.54	1.25	0.92	0.76
Long-Term Debt to EBITDA	25.54	14.85	3.65	3.20	3.03	2.61	1.62	1.66	1.39	1.08	1.02
Debt to NOPAT	-10.94	-14.69	10.67	8.13	6.71	5.20	2.99	2.94	2.39	1.78	1.67
Net Debt to NOPAT	-9.83	-13.54	9.70	7.31	6.07	4.80	2.68	2.72	2.15	1.52	1.23
Long-Term Debt to NOPAT	-10.94	-14.69	10.67	8.13	6.71	5.20	2.99	2.94	2.39	1.78	1.67
Altman Z-Score	2.33	2.06	2.55	2.64	2.75	2.92	3.52	3.95	3.63	4.10	4.09
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.08	1.09	1.18	1.23	1.27	1.28	1.18	1.20	1.33	1.27	1.35
Quick Ratio	0.93	0.95	1.06	1.11	1.16	1.18	1.09	1.12	1.24	1.18	1.27
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	317	212	-241	-198	-129	-242	159	90	-7.71	88	28
Operating Cash Flow to CapEx	929.03%	448.91%	346.33%	364.98%	448.53%	-137.76%	576.00%	747.35%	248.38%	468.77%	557.00%
Free Cash Flow to Firm to Interest Expense	25.70	9.19	-16.71	-12.58	-7.73	-12.02	13.81	7.36	-0.75	7.50	3.08
Operating Cash Flow to Interest Expense	7.52	3.15	4.62	6.33	4.89	-2.04	14.92	16.24	4.23	9.80	12.69
Operating Cash Flow Less CapEx to Interest Expense	6.71	2.45	3.28	4.60	3.80	-3.52	12.33	14.06	2.53	7.71	10.41
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.08	1.12	1.15	1.19	1.21	1.30	1.44	1.55	1.57	1.74	1.91
Accounts Receivable Turnover	4.90	4.78	4.86	4.83	4.25	4.50	4.76	4.93	4.31	5.31	6.48
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	15.31	15.80	15.96	17.27	19.92	22.25	24.94	27.92	33.81	37.94	40.79
Accounts Payable Turnover	7.78	7.82	7.31	7.19	5.94	6.19	6.65	7.43	6.65	7.82	9.97
Days Sales Outstanding (DSO)	74.43	76.42	75.05	75.54	85.93	81.18	76.65	74.03	84.65	68.68	56.30
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	46.90	46.69	49.92	50.77	61.45	58.95	54.91	49.12	54.91	46.66	36.61
Cash Conversion Cycle (CCC)	27.53	29.73	25.12	24.78	24.49	22.23	21.75	24.91	29.74	22.02	19.68
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,610	1,680	1,919	1,947	2,002	2,034	1,657	1,722	1,843	1,761	1,755
Invested Capital Turnover	1.58	1.61	1.72	1.76	1.81	2.00	2.40	2.53	2.69	2.98	3.19
Increase / (Decrease) in Invested Capital	-391	-354	261	226	158	273	-98	-19	99	2.46	71
Enterprise Value (EV)	1,829	1,884	2,639	3,017	3,510	4,033	4,076	5,282	4,295	5,174	5,208
Market Capitalization	934	911	1,611	1,947	2,362	2,830	3,236	4,326	3,407	4,456	4,585
Book Value per Share	$18.72	$18.56	$23.44	$23.08	$22.41	$22.00	$21.51	$19.33	$23.27	$24.08	$26.17
Tangible Book Value per Share	($14.25)	($15.03)	($16.54)	($17.47)	($18.62)	($19.96)	($13.91)	($15.18)	($10.57)	($8.50)	($6.98)
Total Capital	1,711	1,762	2,021	2,067	2,124	2,136	1,757	1,800	1,940	1,887	1,976
Total Debt	996	1,056	1,131	1,190	1,270	1,305	939	1,034	984	844	843
Total Long-Term Debt	996	1,056	1,131	1,190	1,270	1,305	939	1,034	984	844	843
Net Debt	895	973	1,028	1,070	1,148	1,203	840	956	888	718	623
Capital Expenditures (CapEx)	9.98	16	19	27	18	30	30	26	17	25	20
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-11	38	63	83	116	153	95	127	239	171	159
Debt-free Net Working Capital (DFNWC)	45	49	94	131	167	186	124	134	267	236	315
Net Working Capital (NWC)	45	49	94	131	167	186	124	134	267	236	315
Net Nonoperating Expense (NNE)	-74	46	13	12	12	18	8.14	9.33	7.48	8.95	6.50
Net Nonoperating Obligations (NNO)	895	973	1,028	1,070	1,148	1,203	840	956	888	718	623
Total Depreciation and Amortization (D&A)	40	41	43	45	45	43	41	38	39	38	34
Debt-free, Cash-free Net Working Capital to Revenue	-0.37%	1.29%	2.06%	2.56%	3.34%	4.03%	2.31%	2.89%	4.96%	3.26%	2.90%
Debt-free Net Working Capital to Revenue	1.58%	1.65%	3.06%	4.05%	4.79%	4.90%	3.03%	3.05%	5.55%	4.50%	5.75%
Net Working Capital to Revenue	1.58%	1.65%	3.06%	4.05%	4.79%	4.90%	3.03%	3.05%	5.55%	4.50%	5.75%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.03)	($4.91)	$0.18	$0.43	$0.45	$0.40	$1.39	$1.56	$2.03	$1.96	$2.11
Adjusted Weighted Average Basic Shares Outstanding	38.31M	38.19M	38.20M	38.17M	38.11M	39.17M	38.15M	39.15M	41.38M	44.59M	43.79M
Adjusted Diluted Earnings per Share	($0.03)	($4.90)	$0.18	$0.42	$0.45	$0.40	$1.39	$1.55	$2.02	$1.94	$2.10
Adjusted Weighted Average Diluted Shares Outstanding	38.31M	38.19M	38.29M	38.23M	38.20M	39.34M	38.33M	39.34M	41.57M	44.87M	44.04M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	38.28M	38.19M	38.07M	38.00M	38.00M	37.89M	37.79M	37.99M	39.65M	44.59M	43.34M
Normalized Net Operating Profit after Tax (NOPAT)	8.75	-142	20	28	30	30	61	70	92	91	99
Normalized NOPAT Margin	1.27%	-19.30%	2.90%	3.76%	3.62%	3.72%	7.18%	7.09%	8.13%	8.06%	8.69%
Pre Tax Income Margin	0.03%	-30.72%	1.14%	2.97%	2.84%	1.71%	8.83%	8.02%	10.25%	9.55%	11.19%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.01	-8.76	1.54	2.40	2.40	1.69	7.53	7.53	12.25	10.13	15.22
NOPAT to Interest Expense	-6.06	-6.13	1.38	1.77	1.79	1.51	5.31	5.77	8.93	7.71	11.04
EBIT Less CapEx to Interest Expense	0.21	-9.46	0.21	0.66	1.31	0.21	4.94	5.36	10.55	8.04	12.94
NOPAT Less CapEx to Interest Expense	-6.87	-6.84	0.05	0.04	0.69	0.03	2.72	3.60	7.22	5.62	8.76
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	173.74%	201.61%	214.16%	187.82%	136.98%	129.89%	84.56%

Frequently Asked Questions About AMN Healthcare Services' Financials

When does AMN Healthcare Services's financial year end?

According to the most recent income statement we have on file, AMN Healthcare Services' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has AMN Healthcare Services' net income changed over the last 10 years?

AMN Healthcare Services' net income appears to be on an upward trend, with a most recent value of -$146.98 million in 2024, falling from $33.22 million in 2014. The previous period was $210.68 million in 2023. See AMN Healthcare Services' forecast for analyst expectations on what’s next for the company.

What is AMN Healthcare Services's operating income?

AMN Healthcare Services's total operating income in 2024 was -$102.67 million, based on the following breakdown:

Total Gross Profit: $919.38 million
Total Operating Expenses: $1.02 billion

How has AMN Healthcare Services revenue changed over the last 10 years?

Over the last 10 years, AMN Healthcare Services' total revenue changed from $1.04 billion in 2014 to $2.98 billion in 2024, a change of 188.0%.

How much debt does AMN Healthcare Services have?

AMN Healthcare Services' total liabilities were at $1.71 billion at the end of 2024, a 18.3% decrease from 2023, and a 302.9% increase since 2014.

How much cash does AMN Healthcare Services have?

In the past 10 years, AMN Healthcare Services' cash and equivalents has ranged from $9.58 million in 2015 to $180.93 million in 2021, and is currently $10.65 million as of their latest financial filing in 2024.

How has AMN Healthcare Services' book value per share changed over the last 10 years?

Over the last 10 years, AMN Healthcare Services' book value per share changed from 5.50 in 2014 to 18.56 in 2024, a change of 237.3%.

Related Companies

This page (NYSE:AMN) was last updated on 5/27/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

AMN Healthcare Services (AMN) Financials

Frequently Asked Questions About AMN Healthcare Services' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

AMN Healthcare Services (AMN) Financials

Annual Income Statements for AMN Healthcare Services

Quarterly Income Statements for AMN Healthcare Services

Annual Cash Flow Statements for AMN Healthcare Services

Quarterly Cash Flow Statements for AMN Healthcare Services

Annual Balance Sheets for AMN Healthcare Services

Quarterly Balance Sheets for AMN Healthcare Services

Annual Metrics And Ratios for AMN Healthcare Services

Quarterly Metrics And Ratios for AMN Healthcare Services

Frequently Asked Questions About AMN Healthcare Services' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools